Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma

NCT00242827 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Cephalon